Company:  SUCAMPO PHARMACEUTICALS, ...
Form Type:  25-NSE
Filing Date:  2/13/2018 
CIK:  0001365216 
Address:  805 KING FARM BOULEVARD, SUITE 550 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  (301) 961-3400 
Fiscal Year:  12/31 
Description of Business
We are a global biopharmaceutical company focused on developing, identifying, acquiring and bringing to market innovative medicines that meet unmet medical needs. Our primary focus areas are gastroenterology, ophthalmology, and oncology-related disorders. We currently generate revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development activities. We expect to continue to incur significant expenses for the next several years as we continue our research and development activities, seek additional regulatory approvals and additional indications for our approved products and other compounds and seek strategic opportunities for in-licensing new products. Our operations are conducted through subsidiaries based in the United States (U.S.), Japan and Switzerland. We operate as one segment, which focuses on the development and commercialization of pharmaceutical products.
Register and access this filing in:     
  FORM 25-NSE
  EXHIBIT 99.25